GlassScriptPhysician profile
Kenneth Brian Boyd
NPI 1295905891
$14,915.01
in general payments reported to CMS, 2019-2025
21 companies · $87.85 in 2025
The $87.85 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,831 · 2020: $1,427 · 2021: $532 · 2022: $126 · 2023: $2,225 · 2024: $1,686 · 2025: $87.85.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $2,500 · Travel and Lodging: $959 · Food and Beverage: $540.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $2,500.00 |
| Travel and Lodging | $958.72 |
| Food and Beverage | $540.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $12,506.76 | 2019-2024 | Davinci Xi, Da Vinci Surgical System, Da Vinci Sp |
| Orthofix Medical, INC. | $1,331.98 | 2020 | |
| Medtronic, INC. | $224.18 | 2021 | |
| Davol INC. | $103.59 | 2024 | Phasix Mesh |
| Lemaitre Vascular, INC. | $93.70 | 2019-2022 | |
| Myriad Genetic Laboratories, INC. | $71.24 | 2021 | |
| Ethicon US, LLC | $70.42 | 2020 | |
| Laminate Medical Technologies INC. | $68.00 | 2025 | Vasq |
| Acera Surgical, INC. | $55.07 | 2020-2023 | Restrata Wound Matrix |
| Pharmacosmos Therapeutics INC. | $53.65 | 2023 | Monoferric |
| Misonix INC | $48.66 | 2021 | |
| Sanara Medtech INC. | $46.89 | 2022-2024 | Celleraterx |
| Tactile Systems Technology INC | $42.42 | 2021 | |
| Solventum Corporation | $39.67 | 2024 | Prevena |
| Kci USA, INC. | $39.25 | 2019-2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hollister Incorporated | $24.50 | 2023 | New Image |
| Vertex Pharmaceuticals Incorporated | $19.85 | 2025 | |
| Boston Scientific Corporation | $19.73 | 2021 | |
| Lilly USA, LLC | $19.23 | 2023 | Verzenio, Jaypirca |
| Getinge USA Sales, LLC | $18.89 | 2022 | |
| Kerecis Limited | $17.33 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Boyd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.